ITTBioMed by Edra and DLA Piper, supported by Lendlease, MIND, and T-Factor, recently organized the event “Patents and...
Why gene therapies must go virus-free
Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, where virus ve...
Advancement in Metabolic dysfunction-Associated SteatoHepatitis (MASH) treatment: the first FDA approved drug
The FDA approves Madrigal Pharmaceuticals’ Rezdiffra for Metabolic dysfunction-Associated SteatoHepatitis (MASH), ...
Immunotherapy and cell-based immunotherapy: TILs on stage
CAR-T therapy is one of the most revolutionary approaches of these years, but Tumor-infiltrating lymphocytes (TILs) are...
Breaking barriers: a blood test to study gene expression in the brain
The released markers of activity (RMAs) is a non-invasive monitoring of gene expression in the brain with a simple blood...
From research to the ward, Technology Transfer at IRCCS Galeazzi-Sant’Ambrogio Hospital
Paola Bagnoli, Head of Technology Transfer at IRCCS Galeazzi-Sant’Ambrogio Hospital, part of the San Donato Group, wit...